Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Littlejohn

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Vaccine|May 9, 2018
Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern AustraliaBenjamin C Cheah, Jane Davies, Gurmeet R Singh, et al.
Journal of Medical Virology|November 19, 2016
Genotypic profiles of hepatitis B in African immigrants and their clinical relevanceMaria Christine Thurnheer, Rosalind Edwards, Thomas Ray Schulz, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
International Journal for Equity in Health|December 27, 2022
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
AIDS (London, England)|August 11, 2007
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individualsPeter A Revill, Margaret Littlejohn, Anna Ayres, et al.
Internal Medicine Journal|August 7, 2023
Hepatitis B genotypes in Aboriginal and Torres Strait Islander Australians: correlation with clinical course and implications for managementJosh Hanson, Sharna Radlof, Margaret Littlejohn, et al.
Journal of Viral Hepatitis|December 1, 2019
Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Vaccine|May 9, 2018
Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern AustraliaBenjamin C Cheah, Jane Davies, Gurmeet R Singh, et al.
Journal of Medical Virology|November 19, 2016
Genotypic profiles of hepatitis B in African immigrants and their clinical relevanceMaria Christine Thurnheer, Rosalind Edwards, Thomas Ray Schulz, et al.
Plos One|April 18, 2013
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individualsGail V Matthews, Rachel J Ali, Anchalee Avihingsanon, et al.
Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
International Journal for Equity in Health|December 27, 2022
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
AIDS (London, England)|August 11, 2007
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individualsPeter A Revill, Margaret Littlejohn, Anna Ayres, et al.
Internal Medicine Journal|August 7, 2023
Hepatitis B genotypes in Aboriginal and Torres Strait Islander Australians: correlation with clinical course and implications for managementJosh Hanson, Sharna Radlof, Margaret Littlejohn, et al.
Journal of Viral Hepatitis|December 1, 2019
Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
Pageof 6